Francisco Miguel Bombillar Sáenz

University of Granada | UGR · Departamento de Derecho Administrativo

Objetivo: fazer um estudo comparado entre a Espanha e o Brasil sobre os arranjos político-jurídico-sanitários para a requisição de leitos de UTI pelos sistemas de saúde espanhol e brasileiro durante a pandemia de COVID-19. Metodologia: foi realizado estudo descritivo-comparativo com base em variantes pré-selecionadas e analisadas mediante o método...

Esta contribución se ocupa de uno de los ejes sobre los que se articula la prestación farmacéutica en nuestro sistema sanitario: la receta médica. En este artículo se abordan las notas más relevantes que caracterizan el régimen jurídico de la receta médica en España y en Latinoamérica: concepto, tipos, reconocimiento por otros estados, identificaci...

This paper defends that it is necessary to regulate the cross-border healthcare in the European Union, and, specifically, the recognition of medical prescriptions issued in other Member States. And this, obviously, without neglecting the Public Health protection, verifying the authenticity of the medical prescriptions, whether they were issued by a...

Aunque el acceso al medicamento es un componente crucial dentro del contenido propio del derecho a la protección de la salud, millones de ciudadanos tienen, aún hoy, problemas para acceder a medicamentos esenciales para su salud, en los países en vías de desarrollo y en la Unión Europea. Se expone el régimen jurídico europeo que afecta a los medica...

This section updates readers on the latest developments in pharmaceutical law, giving information on legislation and case law on various matters (such as clinical and pre-clinical trials, drug approval and marketing authorisation, the role of regulatory agencies) and providing analysis on how and to what extent they might affect health and security...

Contents/Sommaire/Sumario:Articles/Articles/Artículos:Paper n. 1, pp. 1-25Francisco Miguel Bombillar Sáenz The “Compassionate Exemption” In Spain: Not Asking for Compassion Paper n. 2, pp. 1-39Giovanni ComandéDiscrimination and Reasonable Accommodation: Insights for a (non) Zero Sum Game Paper n. 3, pp. 1-22Aurélie MahalatchimyBioethics and Europea...

The Royal Decree 1015/2009, June 19th 2009 (RDDMSE) aims to facilitate the access to drugs – the drug in question should be subject to a marketing authorisation application or must be undergoing clinical trials – before approval, in Spain, in patients with a chronical or severely debilitating disease or one considered life threatening and who canno...

The necessity of an authentic continuous formation along the pharmaceutical professional's life regarding the upgrade of their knowledge has made what seems to be a new formative market: the blended learning or b-learning, which combines face-to-face and virtual learning (e-learning).

Miraculous products are a challenge for the pharmaceutical professional and a big risk for the public health. The Spanish Legislation, in special, the Royal Decree 1907/1996 on publicity and commercial promotion of products with intended sanitary purposes try to face this problem, a field where the pharmacists have a starring role guaranteeing cons...

El proceso de Bolonia supone un gran cambio para la universidad, en las formas y en el fondo. Una apuesta decidida por la excelencia en formación e investigación, la internacionalización del sistema universitario y un nuevo enfoque metodológico basado en el "aprendizaje", entendido como la construcción del conocimiento a través de metodologías acti...

Nel presente lavoro di ricerca analizziamo, da una prospettiva tanto giuridica quanto metagiuridica (e, senz’ombra di dubbio, decisamente europeista), il regime giuridico-amministrativo dei farmaci di uso umano nella cui fabbricazione interviene un processo industriale e le nuove vicissitudini a cui il suddetto regime deve far fronte all’interno de...

Tesis Univ. Granada. Departamento de Derecho Administrativo. Leída el 12 de febrero de 2010